FGF amplification an important targeted for head and neck cancer patient? A case report of a patient with FGF amplification treated with erdafitinib

Affiliations

• ¹ Department of Medical Oncology, Hôpital Saint-André, CHU Bordeaux, France; Bordeaux university, Bordeaux, France.
• ² Department of Medical Oncology, Hôpital Saint-André, CHU Bordeaux, France; Bordeaux university, Bordeaux, France; IBGC, CNRS, UMR5095, University of Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France.
• ³ Department of Medical Oncology, Hôpital Saint-André, CHU Bordeaux, France; Bordeaux university, Bordeaux, France; ImmunoConcEpt, CNRS UMR 5164, Bordeaux University, Bordeaux 33076, France.
• ⁴ Department of Medical Oncology, Hôpital Saint-André, CHU Bordeaux, France.
• ⁵ Department of Medical Oncology, Hôpital Saint-André, CHU Bordeaux, France. Electronic address: amaury.daste@chu-bordeaux.fr.